We identified ANC < 3.03 × 103 /μL, T-Bil ≥ 0.6 mg/dL, CRP < 0.13 mg/dL as risk factors for Grade 3/4 neutropenia in standard GnP therapy (CTCAE ver5.0). This evidence concerns the gene CRP and Decreased total neutrophil count.